STOCK TITAN

Better Choice Research Partner, Aimia Pet HealthCo Inc., Signs R&D Partnership Agreement for Development of GLP1 Supplement for Pets

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Very Positive)
Tags
partnership
Rhea-AI Summary
Better Choice Company (NYSE: BTTR) and Aimia Pet HealthCo Inc. (APH) announced a memorandum of understanding with Dr. Nadia Crosignani for the development of a GLP1 supplement for pets. This supplement will be used in combination with Better Choices’ Halo branded toppers or treats for dogs and cats to address pet obesity and associated health issues, tapping into a market with over half of dogs and cats globally classified as overweight or obese.
Positive
  • None.
Negative
  • None.

TAMPA, Fla., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Better Choice Company (NYSE: BTTR) (“Better Choice” or the “Company”), a pet health and wellness company, and its research partner, Aimia Pet HealthCo Inc. (APH), today announced that APH has signed a memorandum of understanding (MOU) with Dr. Nadia Crosignani for the development of a GLP1 supplement for pets. The MOU sets out the basis for Dr. Crosignani to commence research and development of a GLP1 supplement for use in companion animals. Combining a GLP1 supplement with Better Choices’ Halo branded toppers or treats for dogs and cats to treat obesity and other health issues associated with overweight pets is an area of growing interest as more than half of dogs and cats worldwide are classified as overweight or obese.

Dr. Crosignani is a leading international researcher in pet health and a professor of Veterinary Science at the Universidad de la Republic de Uruguay operating in the department of Pharmacology in the Faculty of Veterinary Medicine. Dr. Crosignani holds a MS in Physiology from the University of Rio Grande do Sul, UFRGS, Brazil and a PhD in Anesthesia from the Faculty of Medicine, University of Sao Paulo, UNESP, Brazil. In addition, Dr. Crosignani has a post-doctorate degree from UNESP, Faculty of Medicine, researching in the field of pain management.

“We are pleased to make progress with our R&D partners, APH and Dr. Crosignani. We see the use of the GLP1 supplement as a significant opportunity for the pet health industry and are assembling top tier partners to help Better Choice and our brands, including Halo, become pioneers in this sector,” commented Mike Young, Chairman of the Board for Better Choice.

About Better Choice Company Inc.
Better Choice Company Inc. is a rapidly growing pet health and wellness company focused on providing pet products and services that help dogs and cats live healthier, happier and longer lives. We offer a broad portfolio of pet health and wellness products for dogs and cats sold under our Halo brand across multiple forms, including foods, treats, toppers, dental products, chews, and supplements. We have a demonstrated, multi-decade track record of success and are well positioned to benefit from the mainstream trends of growing pet humanization and consumer focus on health and wellness. Our products consist of kibble and canned dog and cat food, freeze-dried raw dog food and treats, vegan dog food and treats, oral care products and supplements. Halo’s core products are made with high-quality, thoughtfully sourced ingredients for natural, science-based nutrition. Each innovative recipe is formulated with leading veterinary and nutrition experts to deliver optimal health. For more information, please visit www.betterchoicecompany.com.

Forward Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words “believe,” “may,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “could,” “target,” “potential,” “is likely,” “will,” “expect” and similar expressions, as they relate to us, are intended to identify forward-looking statements. The Company has based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs. Some or all of the results anticipated by these forward-looking statements may not be achieved. Further information on the Company’s risk factors is contained in our filings with the SEC. Any forward-looking statement made by us herein speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.

Company Contact:
Better Choice Company Inc.
Kent Cunningham, CEO

Investor Contact:
KCSA Strategic Communications
Valter Pinto, Managing Director
T: 212-896-1254
Valter@KCSA.com 


FAQ

What is the memorandum of understanding about?

The MOU is for the development of a GLP1 supplement for pets in collaboration with Dr. Nadia Crosignani.

Who is Dr. Nadia Crosignani?

Dr. Nadia Crosignani is a leading international researcher in pet health and a professor of Veterinary Science at the Universidad de la Republic de Uruguay.

What is the potential market for the GLP1 supplement?

The supplement targets the market of overweight or obese dogs and cats, which accounts for more than half of the global pet population.

Who commented on the progress of the R&D partnership?

Mike Young, Chairman of the Board for Better Choice, expressed satisfaction with the progress of the R&D partnership with APH and Dr. Crosignani.

Better Choice Company Inc.

NYSE:BTTR

BTTR Rankings

BTTR Latest News

BTTR Stock Data

3.85M
1.57M
21.76%
15.85%
2.01%
Packaged Foods
Beverages
Link
United States of America
TAMPA